Company lists · Data refreshed September 2026
Top 25 Cell therapy investors worldwide
RevenueBase identified 782 cell therapy investors worldwide as of September 2026 and tracks 18,308 professional contacts across them, including 8,630 with verified work emails. The United States is the largest market and Boston the largest hub.
This list covers cell therapy investors worldwide, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 19, 2026. Country and city lists for cell therapy investors follow the table.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest cell therapy investors worldwide
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 3,766 contacts → | ||||
Strong evidence “At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 2 | 985 contacts → | ||||
Partial evidence “Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 3 | 712 contacts → | ||||
Strong evidence “Autolus is a CAR T cell therapy company.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 4 | 499 contacts → | ||||
Strong evidence “BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 5 | 313 contacts → | ||||
Strong evidence “Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K- and U.S-based biotechnology hub locations.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 6 | 279 contacts → | ||||
Strong evidence “Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 7 | 251 contacts → | ||||
Indirect evidence “Founded in 2004, RA Capital Management is an active, multi-stage investment manager dedicated to evidence-based, science-led investing in public and private healthcare, life…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 8 | 247 contacts → | ||||
Partial evidence “Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 9 | 232 contacts → | ||||
Indirect evidence “Takeda Ventures, Inc.(TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC).” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 10 | 231 contacts → | ||||
Strong evidence “Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 11 | 229 contacts → | ||||
Indirect evidence “Arcellx is now part of Kite, a Gilead company.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 12 | 213 contacts → | ||||
Strong evidence “Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 13 | 207 contacts → | ||||
Partial evidence “Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 14 | 196 contacts → | ||||
Indirect evidence “Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through investment, intelligence, and philanthropy.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 15 | 194 contacts → | ||||
Strong evidence “Atara Biotherapeutics Inc, is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 16 | 183 contacts → | ||||
Strong evidence “Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 17 | 175 contacts → | ||||
Strong evidence “TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 18 | 158 contacts → | ||||
Strong evidence “An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 19 | 155 contacts → | ||||
Strong evidence “Adicet Bio, Inc.(Nasdaq: ACET) is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 20 | 155 contacts → | ||||
Strong evidence “Century Therapeutics is an innovative biotechnology company that is building an industry-leading, allogeneic, iPSC-derived cell therapy platform that integrates cutting-edge gene…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 21 | 154 contacts → | ||||
Strong evidence “Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 22 | 153 contacts → | ||||
Indirect evidence “Celularity, headquartered in Florham Park, N.J, is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 23 | 128 contacts → | ||||
Partial evidence “Driven by passion, strong business ethics and commitment, Regrow Biosciences Pvt Ltd was established with a Vision to become the world's largest stem cell based tissue and organ…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 24 | 120 contacts → | ||||
Strong evidence “A2 Biotherapeutics (A2 Bio) is a clinical-stage biotechnology company developing first-in-class logic-gated cell therapies to address the high unmet need in cancers and other…” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
| 25 | 116 contacts → | ||||
Indirect evidence “RTW is a life sciences investment and innovation firm.” Source: RevenueBase Database · checked Sep 19, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: cell therapy investors. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names cell therapy investors.
- Partial evidence
- Its own public description names part of cell therapy investors, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name cell therapy investors. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 782 cell therapy investors worldwide
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 8,630 reachable decision-makers.
Free signup · no credit card
Cell therapy investors worldwide at a glance
As of Sep 19, 2026Companies by employee count
Email recency is reported on each country list linked below.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among cell therapy investors, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- Coverage
- Every country. Country and city lists for cell therapy investors are linked below.
- What qualifies
- Companies worldwide whose own description of what they do matches “cell therapy investors”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names cell therapy investors), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among cell therapy investors, and records with no verified work email.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 8,630 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 19, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Cell therapy investors by location
2 lists · largest firstEvery Cell therapy investors list RevenueBase publishes, by country and city. Counts are matching companies in each list as of its own refresh date.
Countries
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names cell therapy investors, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many cell therapy investors are there worldwide?
RevenueBase identified 782 cell therapy investors worldwide as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Kite Pharma, headquartered in Santa Monica, tops this list with the largest team on record.
Which country has the most cell therapy investors?
The United States leads with 335 companies, followed by the United Kingdom (25). Every cell therapy investors list by country and city is linked on this page.
Which city has the most cell therapy investors?
Boston leads with 33 headquartered companies, followed by New York (28) and London (18).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 8,630 verified decision-maker contacts tracked across these 782 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 19, 2026.
Ready to reach these companies? Verified emails and direct dials for all 782 cell therapy investors worldwide. Start with a free account, no credit card.
Download this list →Related lists
Browse the directory
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.